Reporting on the real-world utilization of reference rituximab and its biosimilars can help show prescribing habits and reveal cost-saving opportunities. Objectives: Limited data exist on the ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced the United States (U.S.) Food and Drug Administration (FDA) has approved RUXIENCE™ (rituximab-pvvr), a biosimilar to Rituxan ...

Rituximab biosimilar GP2013 demonstrated similar safety and efficacy as its reference agent in patients with previously untreated, advanced follicular lymphoma, according to results from the ...

This closely follows acceptance of its rituximab biosimilar dossier for review by two other regulatory agencies – the European Medicines Agency (EMA) and the United Kingdom’s Medicines and ...

LA, USA, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Rituximab Biosimilar Insight report on 35+ companies and 35+ marketed and pipeline drugs by DelveInsight “Rituximab– Biosimilar Insight, 2020” by ...

Celltrion’s biosimilar marketing strategy in Europe has got seriously confusing after the firm asked to market its rituximab near-copy under four different brands. Its biosimilar of Roche’s ...

The European Commission has approved Rixathon, a biosimilar of the cancer drug rituximab, for use in Europe, according to an announcement from Novartis, whose Sandoz division manufactures the ...

Spectrum Pharmaceuticals and Viropro will work together to develop a biosimilar of Roche/Genentech’s rituximab. The mAb therapeutic made $5.6 billion in worldwide sales during 2009. Patents ...

Seamless reading experience. Save your favourite. Get updates on your preferred social platform Follow us for the latest news, insider access to events and more.

Branded rituximab has been well recognized for its proven efficacy and safety profile. There are still huge unmet needs in China due to the relatively low affordability. IBI301, the biosimilar ...

LA, USA, Oct. 29, 2020 (GLOBE NEWSWIRE) -- RituximabBiosimilar Insight report on 35+ companies and 35+ marketed and pipeline drugs by DelveInsight “Rituximab– Biosimilar Insight, 2020” by ...